A good interview with Blue Reference's Paul Van Eikeren regarding the company's strategy, including a brief mention of its consortium with big pharma companies to develop a QbD enterprise solution based upon its Inference for R platform. (Here is the press release on that consortium from a while back.)
--Paul Thomas
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment